Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.3 USD | +0.19% | -5.42% | +11.95% |
13/05 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
10/05 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.95% | 1.65B | |
+7.72% | 113B | |
+10.92% | 106B | |
+0.41% | 22.27B | |
-11.88% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.58% | 17.24B | |
+6.75% | 14.29B | |
+35.69% | 12.52B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Oppenheimer Adjusts Soleno Therapeutics Price Target to $44 From $39, Maintains Outperform Rating